{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:04:20Z","timestamp":1777363460686,"version":"3.51.4"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"4","content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0018232","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T16:49:47Z","timestamp":1301676587000},"page":"e18232","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":87,"title":["Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma"],"prefix":"10.1371","volume":"6","author":[{"given":"Lory","family":"Santarelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Strafella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Staffolani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Amati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Emanuelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Sartini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damiano","family":"Carbonari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Bracci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elettra","family":"Pignotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Mazzanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Sabbatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzo","family":"Ranaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Neuzil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Tomasetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,4,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1164\/ajrccm.157.1.96-11086","article-title":"Environmental exposure to crocidolite and mesothelioma. Exposure-response relationships.","volume":"157","author":"J Hansen","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/1874467210902020190","article-title":"Malignant mesothelioma: Biology, diagnosis and new therapeutic approaches.","volume":"2","author":"M Tomasetti","year":"2009","journal-title":"Curr Mol Pharmacol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1183\/09031936.96.09010017","article-title":"CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions.","volume":"9","author":"S Romero","year":"1996","journal-title":"Eur Respir J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":"Asbestos exposure, pleural mesothelioma, and serum osteopontin levels.","volume":"353","author":"HI Pass","year":"2005","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1164\/rccm.200511-1789OC","article-title":"Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma.","volume":"173","author":"A Scherpereel","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1158\/1055-9965.EPI-07-0607","article-title":"Profiling tumour-associated markers for early detection of malignant mesothelioma: an epidemiological study.","volume":"17","author":"M Amati","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.rmed.2009.05.017","article-title":"Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: A meta-analysis.","volume":"104","author":"L Luo","year":"2010","journal-title":"Respir Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma.","volume":"366","author":"BW Robinson","year":"2005","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/ijc.25162","article-title":"miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.","volume":"127","author":"HE Rauhala","year":"2010","journal-title":"Int J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4161\/cc.7.16.6533","article-title":"Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer.","volume":"7","author":"D Lodygin","year":"2008","journal-title":"Cell Cycle"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions.","volume":"37","author":"A Krek","year":"2005","journal-title":"Nat Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1467-789X.2009.00659.x","article-title":"Role of microRNAs in obesity and the metabolic syndrome.","volume":"11","author":"HM Heneghan","year":"2010","journal-title":"Obes Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.4161\/cc.8.21.9837","article-title":"MicroRNA-145 in vascular smooth muscle cell biology: A new therapeutic target for vascular disease.","volume":"8","author":"C Zhang","year":"2009","journal-title":"Cell Cycle"},{"key":"ref14","first-page":"871313","article-title":"Searching for MIND: microRNAs in neurodegenerative diseases.","volume":"9","author":"C Barbato","year":"2009","journal-title":"J Biomed Biotechnol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1757-2215-2-11","article-title":"Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancer.","volume":"2","author":"PP Shah","year":"2009","journal-title":"J Ovarian Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.","volume":"9","author":"N Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1677\/ERC-09-0172","article-title":"MicroRNAs and prostate cancer.","volume":"17","author":"V Coppola","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer.","volume":"6","author":"A Esquela-Kerscher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers.","volume":"6","author":"GA Calin","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1378\/chest.108.4.1122","article-title":"A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.","volume":"108","author":"VW Rusch","year":"1995","journal-title":"Chest"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJM197112022852301","article-title":"Effect of low concentration of asbestos: Clinical environmental, radiologic and epidemiological observations in shipyard pipe coverers and controls.","volume":"285","author":"RLH Murphy","year":"1971","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection.","volume":"105","author":"PS Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.","volume":"18","author":"X Chen","year":"2008","journal-title":"Cell Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","article-title":"Circulating microRNAs, potential biomarkers for drug-induced liver injury.","volume":"106","author":"K Wang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12156-007-0011-7","article-title":"Advances in diagnosis and treatment of malignant mesothelioma.","volume":"1","author":"GV Scagliotti","year":"2007","journal-title":"Oncol Rev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00001622-200303000-00004","article-title":"The role of surgery in diagnosis and treatment of malignant pleural mesothelioma.","volume":"15","author":"DA Waller","year":"2003","journal-title":"Curr Opin Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncponc1039","article-title":"Advances in the systemic therapy of malignant pleural mesothelioma.","volume":"5","author":"DA Fennell","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma.","volume":"353","author":"BW Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.semtcvs.2009.06.007","article-title":"Current status of screening for malignant pleural mesothelioma.","volume":"21","author":"HI Pass","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma.","volume":"362","author":"BW Robinson","year":"2003","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1164\/rccm.200807-1125OC","article-title":"Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment.","volume":"179","author":"BD Grigoriu","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1556-0864(15)30366-X","article-title":"Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.","volume":"1","author":"P Ellis","year":"2006","journal-title":"J Thorac Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers.","volume":"435","author":"J Lu","year":"2005","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1093\/hmg\/ddm056","article-title":"miRNAs in cancer: approaches, aetiology, diagnostics and therapy.","volume":"16","author":"C Blenkiron","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2174\/092986709787581833","article-title":"MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets.","volume":"16","author":"C Ortholan","year":"2009","journal-title":"Curr Med Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/gcc.20669","article-title":"CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma - an miRNA microarray analysis.","volume":"48","author":"M Guled","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.","volume":"42","author":"S Busacca","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref38","article-title":"Downregulated MicroRNAs in the differential diagnosis of malignant pleural mesothelioma.","author":"GV Gee","year":"2010","journal-title":"Int J Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.lungcan.2009.01.010","article-title":"MiR-126 restoration down-regulates VEGF and inhibits the growth of lung cancer cell lines in vitro and in vivo.","volume":"66","author":"B Liu","year":"2009","journal-title":"Lung Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/362841a0","article-title":"Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.","volume":"362","author":"KJ Kim","year":"1993","journal-title":"Nature"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1371\/journal.pone.0000116","article-title":"MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia.","volume":"1","author":"Z Hua","year":"2006","journal-title":"PLOS One"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/14712590902932889","article-title":"MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases.","volume":"9","author":"MA Cortez","year":"2009","journal-title":"Expert Opin Biol Ther"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0018232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T18:45:45Z","timestamp":1540320345000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0018232"}},"subtitle":[],"editor":[{"given":"Siyaram","family":"Pandey","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0018232","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,1]]}}}